(Q35215020)

7 August 2017

Biological therapies for eating disorders (English)

1 reference

7 August 2017

1 reference

James Edward Mitchell

series ordinal

1

object named as

James E Mitchell

1 reference

7 August 2017

James Roerig

2

1 reference

PubMed ID

23658094

7 August 2017

Kristine Steffen

series ordinal

3

1 reference

7 August 2017

1 July 2013

1 reference

International Journal of Eating Disorders

7 August 2017

1 reference

7 August 2017

46

1 reference

7 August 2017

5

1 reference

7 August 2017

470-477

1 reference

The effect of atypical antipsychotic medications in individuals with anorexia nervosa: a systematic review and meta-analysis.

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Pharmacological management of binge eating disorder: current and emerging treatment options

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Repetitive transcranial magnetic stimulation in anorexia nervosa: a pilot study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Atypical antipsychotics and anorexia nervosa: a review

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Zonisamide Combined with Cognitive Behavioral Therapy in Binge Eating Disorder: A One-year Follow-up Study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

The outcome of bulimia nervosa: findings from one-quarter century of research

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

What potential role is there for medication treatment in anorexia nervosa?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Behavioral neuroendocrinology and treatment of anorexia nervosa

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

A randomized, placebo-controlled trial of sertraline in the treatment of night eating syndrome

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Treatment of bulimia nervosa with sertraline: a randomized controlled trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Topiramate in the long-term treatment of binge-eating disorder associated with obesity

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

An open trial of light therapy for women with seasonal affective disorder and comorbid bulimia nervosa.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Placebo-controlled trial of sertraline in the treatment of binge eating disorder.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Effects of fluvoxamine on depression, anxiety, and other areas of general psychopathology in bulimia nervosa.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Medication and psychotherapy in the treatment of bulimia nervosa

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

A controlled study of light therapy for bulimia nervosa.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled cross-over study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Long-term outcome of antidepressant treatment for bulimia nervosa

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

An open trial of fluoxetine in patients with anorexia nervosa

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Predictors of attitudes towards treatments for bulimia nervosa.

13 July 2018

1 reference

Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.

21 January 2018

1 reference

A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment

21 January 2018

1 reference

A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: a high placebo response

21 January 2018

1 reference

Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study

21 January 2018

1 reference

Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial

21 January 2018

1 reference

Linear eaters turned decelerated: reduction of a risk for disordered eating?

21 January 2018

1 reference

Normalizing eating behavior reduces body weight and improves gastrointestinal hormonal secretion in obese adolescents.

21 January 2018

1 reference

Treatment of childhood obesity by retraining eating behaviour: randomised controlled trial

21 January 2018

1 reference

Mandometer treatment not superior to treatment as usual for anorexia nervosa

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation in bulimia nervosa: preliminary results of a single-centre, randomised, double-blind, sham-controlled trial in female outpatients.

21 January 2018

1 reference

Body weight and leptin plasma levels during treatment with antipsychotic drugs

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Cognitive Behavioral Therapy and Fluoxetine for Binge Eating Disorder: Two-year Follow-up*

26 September 2018

1 reference

Antidepressants versus placebo for people with bulimia nervosa

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372845

Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study

15 November 2018

1 reference

12 December 2020

Bright light therapy decreases winter binge frequency in women with bulimia nervosa: a double-blind, placebo-controlled study

1 reference

12 December 2020

Light therapy in bulimia nervosa: a double-blind, placebo-controlled study

1 reference

12 December 2020

Fluoxetine for bulimia nervosa following poor response to psychotherapy

1 reference

12 December 2020

A method for the control of eating rate: a potential intervention in eating disorders

1 reference

12 December 2020

Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment

1 reference

12 December 2020

d-fenfluramine treatment of binge eating disorder

1 reference

12 December 2020

Neuroleptics in the short-term treatment of anorexia nervosa. A double- blind placebo-controlled study with sulpiride

1 reference

12 December 2020

Anorexia nervosa. Treatment efficacy of cyproheptadine and amitriptyline

1 reference

12 December 2020

Residual symptoms after partial remission: an important outcome in depression

1 reference

12 December 2020

Does fluoxetine augment the inpatient treatment of anorexia nervosa?

1 reference

12 December 2020

Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial

1 reference

12 December 2020

A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters

1 reference

12 December 2020

An open trial of reboxetine in obese patients with binge eating disorder

1 reference

12 December 2020

Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1002/EAT.22104

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

PubMed ID

23658094